UK businesses can apply for a share of up to £7 million to explore and evaluate the commercial potential of a scientific idea to solve a healthcare challenge.
Programme: Innovate UK
Award: Share of up to £7 million
Opens: 21st Jan 2019
Closes: 3rd Apr 2019
The aim of the Biomedical Catalyst is to support the development of innovative healthcare products, technologies and processes. These can include (but are not limited to):
The aim of this competition is to enable companies to create a data package that can support the subsequent testing of your products or carry out evaluations in a clinical setting or other relevant environment. This can include:
Your project must focus on the development of a product or process that is an innovative solution to a health and care challenge.
Support is available for any life science sector or discipline, including (but not limited to):
If you choose the innovation area ‘Diagnostics, medical technology and devices’, you must indicate in the initial project summary whether your project falls within ‘Diagnostics’ or ‘Medical technology and devices’.
To lead a project or work alone you must:
You can work alone or in partnership with others (SMEs, academics or research organisations).
The lead must claim funding.
To be a collaborator you must:
Your project’s total eligible costs must be between £250,000 and £4 million.
Your project must start by 1 September 2019 and end by 31 March 2021. It must last at least 1 year.
For feasibility studies (early stage projects only) and industrial research projects, you could get funding for your eligible project costs of:
The research organisations in your consortium can share up to 50% of the total eligible project costs. If your consortium contains more than one research organisation, this maximum will be shared between them.
Innovate UK will not fund projects as part of this competition that are in scope for the Biomedical Catalyst feasibility or primer awards.